Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
492.14 USD | -0.48% | -0.73% | -15.23% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 675M | 883M | 1.3B | 1.73B | 2.17B | |||||
Total Revenues | 675M | 883M | 1.3B | 1.73B | 2.17B | |||||
Cost of Goods Sold, Total | 130M | 167M | 259M | 314M | 345M | |||||
Gross Profit | 545M | 716M | 1.04B | 1.42B | 1.82B | |||||
Selling General & Admin Expenses, Total | 433M | 561M | 795M | 1.08B | 1.31B | |||||
R&D Expenses | 158M | 206M | 302M | 442M | 618M | |||||
Other Operating Expenses, Total | 591M | 767M | 1.1B | 1.53B | 1.93B | |||||
Operating Income | -46.46M | -50.83M | -54.8M | -109M | -108M | |||||
Interest Expense, Total | -22.82M | -37.05M | -30.28M | -3.76M | -3.8M | |||||
Interest And Investment Income | 19.43M | 7.77M | 1.17M | 15M | 58.83M | |||||
Net Interest Expenses | -3.39M | -29.28M | -29.11M | 11.24M | 55.03M | |||||
Currency Exchange Gains (Loss) | -393K | -711K | -1.65M | -5.17M | -2.97M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | -50.25M | -80.82M | -85.56M | -103M | -55.76M | |||||
Restructuring Charges | - | - | - | - | -96.84M | |||||
Merger & Related Restructuring Charges | -527K | - | - | - | -3.4M | |||||
Gain (Loss) On Sale Of Investments | - | - | 11.74M | -1.66M | -1.7M | |||||
EBT, Incl. Unusual Items | -50.77M | -80.82M | -73.82M | -105M | -158M | |||||
Income Tax Expense | 2.97M | 4.22M | 4.02M | 8.06M | 18.59M | |||||
Earnings From Continuing Operations | -53.75M | -85.03M | -77.84M | -113M | -176M | |||||
Net Income to Company | -53.75M | -85.03M | -77.84M | -113M | -176M | |||||
Net Income - (IS) | -53.75M | -85.03M | -77.84M | -113M | -176M | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | -53.75M | -85.03M | -77.84M | -113M | -176M | |||||
Net Income to Common Excl. Extra Items | -53.75M | -85.03M | -77.84M | -113M | -176M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -1.28 | -1.9 | -1.66 | -2.35 | -3.53 | |||||
Basic EPS - Continuing Operations | -1.28 | -1.9 | -1.66 | -2.35 | -3.53 | |||||
Basic Weighted Average Shares Outstanding | 42.02M | 44.76M | 46.89M | 48.06M | 49.88M | |||||
Net EPS - Diluted | -1.28 | -1.9 | -1.66 | -2.35 | -3.53 | |||||
Diluted EPS - Continuing Operations | -1.28 | -1.9 | -1.66 | -2.35 | -3.53 | |||||
Diluted Weighted Average Shares Outstanding | 42.02M | 44.76M | 46.89M | 48.06M | 49.88M | |||||
Normalized Basic EPS | -0.75 | -1.13 | -1.14 | -1.34 | -0.7 | |||||
Normalized Diluted EPS | -0.75 | -1.13 | -1.14 | -1.34 | -0.7 | |||||
American Depositary Receipts Ratio (ADR) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||
Supplemental Items | ||||||||||
EBITDA | -29.27M | -29.77M | -32.64M | -82.95M | -80.94M | |||||
EBITA | -43.26M | -48.23M | -53.5M | -107M | -103M | |||||
EBIT | -46.46M | -50.83M | -54.8M | -109M | -108M | |||||
EBITDAR | 2.93M | 9.83M | 9.91M | -43.66M | -45.91M | |||||
Total Revenues (As Reported) | 675M | 883M | 1.3B | 1.73B | 2.17B | |||||
Effective Tax Rate - (Ratio) | -5.86 | -5.22 | -5.44 | -7.7 | -11.79 | |||||
Current Domestic Taxes | 479K | 893K | 1.28M | 2.4M | 1.96M | |||||
Current Foreign Taxes | 3.29M | 5.51M | 5.61M | 7.78M | 11.42M | |||||
Total Current Taxes | 3.77M | 6.4M | 6.89M | 10.18M | 13.38M | |||||
Deferred Domestic Taxes | -160K | 116K | -989K | - | - | |||||
Deferred Foreign Taxes | -639K | -2.3M | -1.88M | -2.12M | 5.21M | |||||
Total Deferred Taxes | -799K | -2.18M | -2.87M | -2.12M | 5.21M | |||||
Normalized Net Income | -31.4M | -50.51M | -53.47M | -64.39M | -34.85M | |||||
Interest on Long-Term Debt | 22.89M | 26.49M | 25.39M | 3.76M | 3.71M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 14.9M | 21.9M | 37.3M | 59.4M | 105M | |||||
Selling and Marketing Expenses | 341M | 452M | 650M | 886M | 1.07B | |||||
General and Administrative Expenses | 92.44M | 109M | 145M | 198M | 246M | |||||
Research And Development Expense From Footnotes | 170M | 222M | 325M | 474M | 664M | |||||
Net Rental Expense, Total | 32.2M | 39.6M | 42.55M | 39.29M | 35.03M | |||||
Imputed Operating Lease Interest Expense | 12.67M | 16.8M | 13.73M | 1.56M | 1.34M | |||||
Imputed Operating Lease Depreciation | 19.53M | 22.8M | 28.82M | 37.74M | 33.69M | |||||
Stock-Based Comp., COGS (Total) | 5.96M | 6.94M | 9.39M | 13.47M | 17.61M | |||||
Stock-Based Comp., R&D Exp. (Total) | 33.75M | 39.37M | 61.61M | 108M | 199M | |||||
Stock-Based Comp., S&M Exp. (Total) | 36.6M | 50.55M | 67.41M | 108M | 140M | |||||
Stock-Based Comp., G&A Exp. (Total) | 21.45M | 24.63M | 28.34M | 47.22M | 75.35M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | 1M | |||||
Total Stock-Based Compensation | 97.75M | 121M | 167M | 276M | 433M |